DAPAGLIFLOZINbreakthrough for type-2 diabetes
FULL TECHNICAL AND REGULATORY SUPPORT
THERAPEUTIC INDICATION: ANTI-DIABETES
DAPAGLIFLOZIN is used for the treatment of type-2 diabetes. It is taken as film-coated tablets of 10mg.
Originator: BRISTOL-MYERS SQUIBB in partnership with ASTRA ZENECA
Trade names: FORXIGA®, FARXIGA®
- Reliable supply guaranteed
- Short lead time with full technical and regulatory support
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.